Rajesh Garg, global chief financial officer, Cipla, told CNBC-TV18 that operating profits were impacted in the absence of anti-depressant Escitalopram sales in the US, and higher sales of anti-retroviral (ARV) drugs, where profit margins are low.
first published: Feb 13, 2014 10:18 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

